Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Connect your AI
Get started
Toggle navigation menu
International Flavors & Fragrances
IFF
Concentration Risk %
Concentration Risk % at other companies
Identive
INVE
10.3%
+7.7pp
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
RF Industries
RFIL
100%
0.0pp
Segments
By geography
See full
Net sales attributed to all foreign countries
10%
0.0%
Other financials
Income statement
See full
Revenue
$2.7B
-3.6%
Gross profit
$1.0B
-1.6%
Operating income
$273.0M
+130%
Net income
$169.0M
+117%
EPS (diluted)
$0.66
+117%
Balance sheet
See full
Cash & equivalents
$562.0M
-13.5%
Total debt
$6.3B
-35.5%
Total equity
$14.1B
+7.2%
Total assets
$25.1B
-11.0%
Cash flow
See full
Operating cash flow
$257.0M
+102%
CapEx
$165.0M
-7.8%
Free cash flow
$92.0M
+277%
Valuation
See full
Market cap
$20.23B
+10.7%
Enterprise value
$26.01B
+7.5%
P/E
24.6×
—
P/S
1.9×
+0.3×
Profitability
See full
Gross margin
36.3%
+0.2pp
Operating margin
-3.2%
-1.4pp
Net margin
7.6%
+5.2pp
FCF margin
3.7%
-1.3pp
Returns & leverage
See full
Return on equity
6%
+4.0pp
Debt / equity
0.4×
-0.3×
Current ratio
1.5×
-0.4×